New therapies vie to change the fatal course of amyotrophic lateral sclerosis
Release Date:
Executives from Amylyx Pharmaceuticals Inc. and Clene Inc., along with a key Penn State ALS expert, discuss what the future of medicine holds for patients. Hosted on Acast. See acast.com/privacy for more information.
New therapies vie to change the fatal course of amyotrophic lateral sclerosis